Amoxycillin & Potassium Clavulanate Tablets IP – AASP CLAV 625 – Trusted Antibiotic for Bacterial Infections
AASP CLAV 625
(Amoxicillin 500 mg + Clavulanate Potassium 125 mg)
AASP CLAV 625 provides a powerful combination of amoxicillin and clavulanate potassium, ensuring broad-spectrum antibacterial action with resistance protection. It is a trusted choice for physicians in managing community-acquired infections and resistant bacterial cases.
AASP CLAV 625 is a broad-spectrum antibiotic that combines:
- Amoxicillin (500 mg): A penicillin antibiotic that kills sensitive bacteria.
- Clavulanate Potassium (125 mg): A β-lactamase inhibitor that protects amoxicillin from enzymatic inactivation, thereby extending its antibacterial spectrum.
This synergistic formulation ensures effective coverage against β-lactamase producing pathogens responsible for recurrent or resistant infections.
Therapeutic Indications
AASP CLAV 625 is indicated in the treatment of bacterial infections such as:
- Respiratory tract infections (sinusitis, pneumonia, acute bronchitis)
- ENT infections (otitis media, tonsillitis, pharyngitis)
- Urinary tract infections (UTIs)
- Skin & soft tissue infections
- Bone & joint infections
- Dental infections
Clinical Benefits
✅ Broad spectrum coverage against Gram-positive & Gram-negative bacteria
✅ Protection from β-lactamase resistance
✅ Clinically proven efficacy in upper and lower respiratory infections
✅ Well-established safety profile
Dosage & Administration
- Adults & adolescents (≥40 kg): 1 tablet (AASP CLAV 625) every 12 hours with meals.
- Take at the start of a meal for optimal absorption and reduced GI upset.
- Duration: As prescribed by the physician (typically 5–14 days depending on infection severity).
Do not skip doses. Complete the full course to prevent resistance.
Special Precautions & Warnings
- Contraindicated in patients with:
- Severe renal impairment or dialysis dependence
- History of jaundice/hepatic dysfunction associated with amoxicillin-clavulanate
- Known hypersensitivity to penicillin’s/cephalosporins
- Pregnancy: FDA Category B. Use only if clearly needed.
- Lactation: Amoxicillin appears in breast milk in small amounts; clavulanate not detected. Use with caution.
- Contraceptive interactions: May reduce efficacy of oral contraceptives – advise non-hormonal backup.
Side Effects
Serious (seek medical attention):
- Severe allergic reactions (rash, swelling, difficulty breathing)
- Hepatic dysfunction (jaundice, dark urine, loss of appetite)
- Severe diarrhea (risk of difficile colitis)
Common (self-limiting):
- Nausea, vomiting, mild diarrhea
- Rash or itching
- Vaginal yeast infection / discharge
- Diaper rash in infants
Storage
- Tablets: Store at room temperature, away from moisture and heat.
- Oral suspension: Refrigerate and use within 10 days of reconstitution.
Missed Dose / Overdose
- Missed dose: Take as soon as remembered; skip if near next dose. Do not double dose.
- Overdose symptoms: GI upset, rash, drowsiness, reduced urination. Seek immediate medical attention.
Key Counseling Points for Doctors to Inform Patients
- Take with meals to reduce gastric upset.
- Complete full prescribed course.
- Report severe diarrhea or skin reactions
- Use non-hormonal contraceptives during therapy.
- Avoid unnecessary antibiotic use to reduce resistance.
Buy Now:
Fight bacterial infections effectively with Amoxycillin & Potassium Clavulanate Tablets IP – AASP CLAV 625.
This powerful antibiotic combination helps treat a wide range of bacterial infections, ensuring faster recovery and better health.
✅ Effective against respiratory, urinary, skin, and ear infections
✅ Broad-spectrum antibacterial protection
✅ Clinically proven formulation for reliable results
📦 Product Name: AASP CLAV 625
💊 Composition: Amoxycillin & Potassium Clavulanate Tablets IP
🌐 Buy Now: AASP CLAV 625 on AASP LIFESCIENCES PVT.LTD
Choose AASP CLAV 625 – Your trusted partner in infection control.